COVID-19 is an emerging, rapidly evolving situation.
Funding news for global health researchers March 9, 2020
On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding
opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates
are typically distributed once a week.
Funding Opportunities
NIH funding opportunities focusing on global health and foreign collaboration.
NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply.
- Advancing Vaccine Science to Improve Tuberculosis Treatment Outcomes for People Living With or Without HIV
(R01 Clinical Trial Not Allowed) (RFA-AI-20-010)
AIDS Application Due Dates: Standard AIDS dates apply. - Advancing HIV/AIDS Research within the Mission of the National Institute on Deafness and Other Communication Disorders (NIDCD)
(R01 Clinical Trial Optional) (PAR-20-127)
AIDS Application Due Dates: Standard AIDS dates apply. - Harnessing Natural Killer (NK) Cells to Prevent, Control, or Eradicate HIV
(R01 Clinical Trial Not Allowed) (RFA-AI-20-016)
AIDS Application Due Date: July 28, 2020 - Research Towards Developing a Cure for HBV in HIV/HBV Co-Infection
(R21 Clinical Trial Not Allowed) (PAS-20-121)
AIDS Application Due Dates: Standard AIDS dates apply. - Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD)
(U19 Clinical Trial Not Allowed) (PAR-20-120)
AIDS Application Due Dates: July 28, 2020; March 9, 2021; March 9, 2022 - NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
(U01 Clinical Trials Not Allowed) (PAR-20-124)
Application Receipt Dates: May 11, 2020; May 3, 2021; May 2, 2022 - Strengthening the Impact of Community Health Workers on the HIV Care Continuum in the US
(R01 Clinical Trial Optional) (RFA-NR-20-002)
Application Receipt Date(s): May 13, 2020
Note: Research applications that build upon prior research with community health workers in foreign settings is allowed.
NIH funding opportunities for which United States small business concerns (SBCs) may collaborate with a foreign business entity.
- Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System
(U44 Clinical Trial Optional) (PAR-20-111)
Application Receipt Date(s): August 11, 2020, and more
NIH
Notices of Special Interest (NOSIs) that may be of interest to global health researchers.
- Notice of Special Interest (NOSI): Mechanistic Investigations of Psychosocial Factors Associated with Substance Use Disorders (NOT-DA-20-005)
- Notice of Special Interest (NOSI): Harnessing computational tools for sophisticated analyses of Substance Use Disorder-related behaviors (NOT-DA-20-017)
- Notice of Special Interest (NOSI): Human Molecular Genetics of Substance Use Disorders (NOT-DA-20-030)
- Notice of Special Interest (NOSI): Effects of Cannabis Use and Cannabinoids on the Developing Brain (NOT-DA-20-039)
Funding News
NIH funding news that may be relevant to global health researchers.
- Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD) Exploratory/Developmental Research Projects (UH2 Cooperative Agreement, Clinical Trial Optional (NOT-AA-20-004)
Upcoming Deadlines